NEPHROS INC

NEPHReported to SECin USCIK 0001196298Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 3 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

3
Form 4 lines at NEPHROS INC, most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
WEXFORD CAPITAL LP—Option exercisenothing paid3,765 sharesAug 20, 2026WEXFORD CAPITAL LPnothing paidExercise · Aug 20Option exercise3,765Aug 20, 2026
WEXFORD CAPITAL LP—Option exercise$2,923812 sharesAug 20, 2026WEXFORD CAPITAL LP$2,923Exercise · Aug 20Option exercise812Aug 20, 2026
Amron Arthur H—Awardnothing paid2,418 sharesAug 14, 2026Amron Arthur Hnothing paidAward · Aug 14Award2,418Aug 14, 2026